RTFCCR Clinical Cancer Research Grant
Funding innovative, patient-focused interventional clinical trials (Phases I–III) that aim to transform cancer care, detection, and survivorship outcomes.
🔍 Quick Snapshot
- Provider: Rising Tide Foundation for Clinical Cancer Research
- Next LOI Deadline: 29 June 2025
- Type: Research Grant (Clinical Trials)
- Eligible Applicants: Independent researchers with institutional support
- Focus: Phases I–III interventional clinical trials in cancer
- Geographic Scope: Global
🌍 About the RTFCCR Program
The RTFCCR Grant supports impactful, patient-centered clinical research aimed at improving cancer care through well-designed interventional trials. Projects should focus on detection, treatment, survivorship, or therapy optimization, and must actively involve patient partners in the process. The foundation prioritizes studies that demonstrate innovation, measurable impact, and real-world application. Pre-application support is also available to cover patient partner engagement expenses.
✅ Eligibility
- Researchers with institutional affiliation and independence
- PhD or equivalent, with postdoctoral and faculty-level experience
- Global applicants welcome, with capacity for oversight
- Trial must be interventional (Phases I–III)
- Projects must not duplicate existing funded work
- Proposals submitted in English only
🎁 Benefits
- Funding for patient-centered, global cancer clinical research
- Pre-application support: Up to $1,000 travel, $3,000 engagement compensation
- Access to RTFCCR review and patient partnership best practices
- Recognition and collaboration through a global research network
📝 How to Apply
- Letter of Intent (LOI): Submit via SmartSimple Portal
- Full Application: Invited applicants submit detailed proposals post-LOI acceptance
- Review: Peer-reviewed by panel of scientists, advocates & statisticians
- Decision: Final selection by RTFCCR Board of Directors
- Notification: Within one month of board meeting
📅 Grant Timeline (2025)
- LOI Deadlines: March 9, June 29, November 23
- Board Decisions: May, August, December
- Notifications: Within 1 month of board meeting
- Project Start: Flexible based on readiness
🧬 Help Redefine Global Cancer Trials
Submit your LOI by 29 June and join the movement toward more inclusive, impactful cancer care.
Apply Now via RTFCCR PortalPublished by Growth Forum Malaysia. Empowering global clinical research with inclusive funding awareness.
Official Site: risingtide-foundation.org
📬 Join the Growth Forum Circle
Be the first to know about game-changing opportunities, exclusive funding alerts, and curated insights from changemakers across ASEAN.
✨ Sign Me Up NowNo spam. Just real updates. Unsubscribe anytime.
SDL Youth Assembly 2025
